San Diego, CA, United States of America

Anthony Lai Ling



 

Average Co-Inventor Count = 4.9

ph-index = 5

Forward Citations = 150(Granted Patents)


Company Filing History:


Years Active: 2002-2014

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: **The Innovative Journey of Anthony Lai Ling**

Introduction

Anthony Lai Ling is an accomplished inventor based in San Diego, California. With a remarkable portfolio of 10 patents, he has made significant contributions to the field of pharmaceuticals, particularly in developing novel compounds that can enhance health outcomes. His work exemplifies the intersection of research and practical applications in medicine.

Latest Patents

Among his latest innovations, Anthony has developed benzofuranyl derivatives. These compounds, classified under Formula (I), serve as glucokinase activators. This invention presents pharmaceutical compositions and methods aimed at treating diseases, disorders, or conditions influenced by glucokinase activity. The dual application of these derivatives showcases their potential in enhancing therapeutic strategies.

Career Highlights

Throughout his career, Anthony has made a notable impact while working for prominent companies such as Pfizer Corporation and Novo Nordisk A/S. His experience in these leading organizations has significantly shaped his understanding and expertise in pharmaceutical research and development.

Collaborations

In the course of his professional journey, Anthony has collaborated with talented colleagues like Peter Madsen and Jesper F. Lau. These partnerships have fostered a productive environment that encourages innovation and the sharing of ideas, further advancing their collective work in the industry.

Conclusion

Anthony Lai Ling stands out as a prominent inventor whose work has the potential to change the landscape of medical treatments. His patents and collaborations reflect his commitment to innovation and improving health outcomes for patients worldwide. As he continues to explore new avenues of research, the impact of his contributions will likely resonate in the pharmaceutical community for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…